Scientists Revive Powerful Antibiotic That Superbugs Had Defeated

Topic: Health

Researchers at Cold Spring Harbor Laboratory and Scripps Research have found a way to restore the effectiveness of vancomycin, a powerful antibiotic that had lost its power against superbugs. They used a technique called diversity oriented clicking (DOC) to build a library of compounds that helped them identify a small molecule that blocks an enzyme in bacteria, making vancomycin work again.

Antibiotic resistance is becoming one of the biggest threats to modern medicine. Bacteria are evolving and becoming resistant to drugs that once worked well. This makes common infections harder to treat and can increase the risks associated with surgery, cancer care, and other medical procedures.

To combat this problem, researchers worldwide are searching for ways to stay ahead of these rapidly changing microbes. One promising strategy is not to invent a completely new antibiotic, but to help existing drugs work again. This is the idea behind antibiotic adjuvants, which are companion molecules that do not kill bacteria directly but instead restore the power of antibiotics.

Professor John Moses and his team at Cold Spring Harbor Laboratory have spent years developing chemical reactions that can make the drug discovery process faster and more efficient. They use a technique called diversity oriented clicking (DOC), which was created in the Moses laboratory. With this method, they have built a library containing over 150 different compounds.

Molecules from this collection have already contributed to research on both antibiotic resistance and cancer. Now, through a collaboration with Scripps Research, the library has helped scientists restore the effectiveness of vancomycin. This powerful antibiotic is commonly used against severe infections, including those caused by MRSA and Clostridium difficile (C. diff).

The researchers targeted a bacterial enzyme called secreted antigen A (SagA) and blocked it using a small molecule known as pghi-4. When drug-resistant E. faecium was treated with both vancomycin and pghi-4, the antibiotic regained its ability to kill the bacteria.

Why It Matters

This discovery is important for India because antibiotic resistance is a growing concern in our country too. If we can find ways to make existing antibiotics work again, it could save countless lives and reduce the burden on our healthcare system.

Key Facts

• Researchers at Cold Spring Harbor Laboratory and Scripps Research have found a way to restore the effectiveness of vancomycin, a powerful antibiotic that had lost its power against superbugs.
• They used a technique called diversity oriented clicking (DOC) to build a library of compounds that helped them identify a small molecule that blocks an enzyme in bacteria, making vancomycin work again.
• The researchers targeted a bacterial enzyme called secreted antigen A (SagA) and blocked it using a small molecule known as pghi-4.
• Vancomycin is commonly used against severe infections, including those caused by MRSA and Clostridium difficile (C. diff).
• This discovery could save countless lives and reduce the burden on our healthcare system if we can find ways to make existing antibiotics work again.

Key Terms

Antibiotic resistance

When bacteria become resistant to drugs that once worked well, making common infections harder to treat.

Diversity oriented clicking (DOC)

A technique used by researchers to build a library of compounds that can help identify new molecules with potential medical applications.

Implications

This discovery is important for India because antibiotic resistance is a growing concern in our country too. If we can find ways to make existing antibiotics work again, it could save countless lives and reduce the burden on our healthcare system.